Early postnatal administration of growth hormone increases tuberoinfundibular dopaminergic neuron numbers in Ames dwarf mice.
Hypothalamic tuberoinfundibular dopaminergic (TIDA) neurons secrete dopamine, which inhibits pituitary prolactin (PRL) secretion. PRL has demonstrated neurotrophic effects on TIDA neuron development in PRL-, GH-, and TSH-deficient Ames (df/df) and Snell (dw/dw) dwarf mice. However, both PRL and PRL receptor knockout mice exhibit normal-sized TIDA neuron numbers, implying GH and/or TSH influence TIDA neuron development. The current study investigated the effect of porcine (p) GH on TIDA neuron development in Ames dwarf hypothalamus. Normal (DF/df) and dwarf mice were treated daily with pGH or saline beginning at 3 d of age for a period of 42 d. After treatment, brains were analyzed using catecholamine histofluorescence, tyrosine hydroxylase immunocytochemistry, and bromodeoxyuridine (BrdU) immunocytochemistry to detect BrdU incorporation. DF/df males and df/df treated with pGH experienced increased (P </= 0.01) weight gain compared with those treated with saline. DF/df had greater (P </= 0.01) TIDA neuron numbers than df/df, regardless of treatment. TIDA neuron number in pGH-treated df/df was greater (P </= 0.01) than in saline-treated df/df. Zona incerta and periventricular dopamine neurons were not affected by treatment or genotype. There was no effect of genotype or treatment on BrdU incorporation in the arcuate nucleus, median eminence, or periventricular region surrounding the third ventricle. Saline-treated df/df experienced decreased (P </= 0.05) dentate gyrus BrdU incorporation compared with saline-treated DF/df. In the lateral ventricle, pGH-treated males had greater BrdU immunoreactivity than pGH-treated females. The results show an effect of pGH on TIDA neuron development, although this effect is less potent than that of PRL, and likely GH-induced preservation of TIDA neurons rather than generation of new TIDA neurons via neurogenesis.
Khodr
Christina E
CE
Neuroscience Program, Tulane University School of Medicine, New Orleans, LA 70112, USA.
Clark
Sara
S
Bokov
Alex F
AF
Richardson
Arlan
A
Strong
Randy
R
Hurley
David L
DL
Phelps
Carol J
CJ
D000818:Animals; D001835:Body Weight / Q000187:drug effects / Q000235:genetics; D002395:Catecholamines / Q000378:metabolism; D004298:Dopamine / Q000378:metabolism*; D004392:Dwarfism / Q000378:metabolism*; D005260:Female; D005838:Genotype; D013006:Growth Hormone / Q000008:administration & dosage / Q000494:pharmacology*; D007031:Hypothalamus / Q000166:cytology / Q000187:drug effects / Q000378:metabolism; D007150:Immunohistochemistry; D008297:Male; D051379:Mice; D009474:Neurons / Q000166:cytology* / Q000187:drug effects* / Q000378:metabolism; D012737:Sex Factors; D013552:Swine; D013997:Time Factors; D014446:Tyrosine 3-Monooxygenase / Q000378:metabolism
D002395:Catecholamines; D013006:Growth Hormone; D014446:Tyrosine 3-Monooxygenase; D004298:Dopamine
Brain Res. 1973 Mar 15;51:193-205
4706010
Endocrinology. 2005 Mar;146(3):1138-44
15564324
Endocrinology. 1984 Mar;114(3):904-13
6141934
Endocrinology. 1993 Oct;133(4):1860-70
8104778
Endocrinology. 2008 Apr;149(4):2010-8
18096658
Science. 2005 Oct 28;310(5748):679-83
16254185
Biochem Soc Trans. 1990 Dec;18(6):1206
2088869
Cell Tissue Res. 1985;240(1):19-25
3995539
Endocrinology. 1997 Jul;138(7):2849-55
9202227
J Neurocytol. 1997 Jul;26(7):479-90
9306246
Proc Soc Exp Biol Med. 1994 May;206(1):6-23
7910409
Nature. 1996 Nov 28;384(6607):327-33
8934515
J Endocrinol. 2009 Apr;201(1):141-50
19171566
J Neuroendocrinol. 1999 Mar;11(3):229-36
10201819
J Neuroendocrinol. 1994 Apr;6(2):145-52
7914133
Genes Dev. 1997 Jan 15;11(2):167-78
9009200
Endocrinology. 1993 Jun;132(6):2715-22
8504771
Brain Res. 1987 Jul 28;416(2):354-8
2887254
J Neuroendocrinol. 2009 Jun;21(6):558-67
19500226
J Clin Endocrinol Metab. 1981 Feb;52(2):314-8
6780590
J Endocrinol. 1977 Aug;74(2):223-9
894170
Endocrinology. 2002 Apr;143(4):1270-9
11897683
Endocrinology. 2009 Jul;150(7):3145-52
19299456
Neuron. 1997 Jul;19(1):127-38
9247269
J Clin Endocrinol Metab. 1982 Jan;54(1):6-16
6119321
Proc Soc Exp Biol Med. 1999 Oct;222(1):39-58
10510245
Endocrinology. 2004 Dec;145(12):5656-64
15345680
Endocrinology. 1989 Jan;124(1):69-76
2462495
Annu Rev Physiol. 2002;64:47-67
11826263
Neuroendocrinology. 1994 Mar;59(3):189-96
7909141
Nature. 1990 Oct 11;347(6293):528-33
1977085
ScientificWorldJournal. 2006 Jan 18;6:53-80
16432628
J Comp Neurol. 2007 Nov 10;505(2):209-20
17853440
Proc Natl Acad Sci U S A. 1929 Sep 15;15(9):733-4
16577229
J Clin Endocrinol Metab. 1987 Jun;64(6):1136-41
3553220
Neuroendocrinology. 2000 Jul;72(1):2-10
10940733
Endocrinology. 1981 Dec;109(6):2069-75
7308142
Brain Res Bull. 1981 Nov;7(5):585-94
7317798
Neuroendocrinology. 1986;42(3):237-47
2869425
Endocr Rev. 2001 Dec;22(6):724-63
11739329
EMBO J. 1997 Dec 1;16(23):6926-35
9384572
J Neurosci. 2001 Sep 1;21(17):6706-17
11517260
Exp Neurol. 2005 Apr;192(2):251-64
15755543
Physiol Rev. 1999 Apr;79(2):511-607
10221989
Endocrinology. 1998 Sep;139(9):3691-5
9724019
Peptides. 1986 Jan-Feb;7(1):155-9
3520509
Histochemistry. 1978 Sep 28;57(4):285-95
102616